The non-canonical target PARP16 contributes to polypharmacology of the PARP inhibitor talazoparib and its synergy with WEE1 inhibitors

Autor: Palve, Vinayak, Knezevic, Claire E., Bejan, Daniel S., Luo, Yunting, Li, Xueli, Novakova, Silvia, Welsh, Eric A., Fang, Bin, Kinose, Fumi, Haura, Eric B., Monteiro, Alvaro N., Koomen, John M., Cohen, Michael S., Lawrence, Harshani R., Rix, Uwe
Zdroj: In Cell Chemical Biology 17 February 2022 29(2):202-214
Databáze: ScienceDirect